Phase 1 study of autologous T cells bearing fully human chimeric antigen receptors targeting mesothelin in mesothelin-expressing cancers

Molecular Therapy 2026 Open access

Read full text
Authors: Julie S. Barber-Rotenberg, Andrew R. Haas, Charu Aggarwal, Mark H. O'Hara, Elizabeth Hexner, Edward Pequignot, Emily Dowd, Sonia Ndeupen, Elina Thai, Fang Chen, Bike Su Oner, Cory Czuczman
+18 more Vanessa Gonzalez, Joseph A. Fraietta, Wei-Ting Hwang, Anne Chew, Julie K. Jadlowsky, Amy Marshall, Kim-Marie Shea, Yan Jiang, Angela Cosey, Regina Ferthio, Bruce Levine, Gabriela Plesa, Don L. Siegel, Regina M. Young, Neil C. Sheppard, Steven M. Albelda, Carl H. June, János L. Tanyi
DOI: 10.1016/j.ymthe.2026.01.021
Cited by: 2
References: 29

Fields of Study & Subjects

CAR-T cell therapy research Occupational and environmental lung diseases Immunotherapy and Immune Responses

Publication details

Journal / source
Molecular Therapy
Publisher
Elsevier BV
Volume
34
Issue
5
Pages
2653–2665
Publication date
21 January 2026
Language
EN